Kaplan–Meier survival analysis confirmed that high RBP-4 levels significantly increased the risk of adverse outcomes, highlighting its potential as a prognostic marker for risk stratification in HF, with notable implications for both HFpEF and HFrEF populations [98]. The gene discussed is RBP4; the disease is hydrops fetalis.